[Liberal red blood cell transfusion may increase mortality]

Area of Science:

• Transfusion Medicine
• Immunology
• Oncology

Background:

• Allogeneic red blood cell transfusion is associated with known adverse effects.
• Emerging evidence suggests transfusions may independently increase mortality, infection risk, and cancer recurrence.

Purpose of the Study:

• To review the potential risks of allogeneic red blood cell transfusion.
• To discuss the balance between transfusion risks and anemia risks.
• To highlight the need for further research in specific patient populations.

Main Methods:

• Literature review of studies investigating transfusion outcomes.
• Analysis of proposed mechanisms including transfusion-related immune modulation and storage lesions.
• Discussion of the comparative risks of anemia versus transfusion.

Main Results:

• Allogeneic red blood cell transfusion may be linked to increased mortality, infection, and cancer recurrence.
• Transfusion-related immune modulation and storage lesions are potential contributing factors.
• Anemia itself is associated with increased mortality, necessitating a risk-benefit assessment.

Conclusions:

• The potential harms of allogeneic red blood cell transfusion require careful consideration.
• Balancing the risks of anemia against the risks of transfusion is crucial for clinical decision-making.
• Further well-designed studies are essential to define optimal transfusion strategies for distinct patient categories.